Coverage and Compliance of Human Papillomavirus Vaccines in Paris: Demonstration of Low Compliance With Non-School-Based Approaches

Harper, 2009, Prevention of human papillomavirus infections and associated diseases by vaccination: A new hope for global public health, Public Health Genomics, 12, 319, 10.1159/000214922

Koulova, 2008, Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008, Vaccine, 26, 6529, 10.1016/j.vaccine.2008.08.067

Lévy-Bruhl, 2009, The current state of introduction of HPV vaccination into national immunisation schedules in Europe: Results of the VENICE 2008 survey, Eur J Cancer, 45, 2709, 10.1016/j.ejca.2009.07.023

Bergeron, 2008, Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France, Int J Technol Assess Health Care, 24, 10, 10.1017/S0266462307080026

2009, Vaccination schedule and recommendations from the “Haut conseil de la santé publique” in France, Bull Epidémiol Hebdomadaire, 16-17, 145

Breakthrough Vaccine Victim of Bad Publicity. Canadian National Post, February 19, 2008. Available at: www.nationalpost.com/news/canada/Story.html?id=317535.

Brabin, 2008, Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: Prospective cohort study, BMJ, 336, 1056, 10.1136/bmj.39541.534109.BE

Brotherton, 2008, Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia, Commun Dis Intell, 32, 457

2008, Vaccination coverage among adolescents aged 13-17 years—United States, 2007, Morb Mortal Wkly Rep, 57, 1100

2007, Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions, N Engl J Med, 356, 1915, 10.1056/NEJMoa061741

Paavonen, 2009, Greenacre M. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomized study in young women, Lancet, 374, 301, 10.1016/S0140-6736(09)61248-4

Stephan, 2008

Stephan, 2008

Watson, 2009, Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia, Aust N Z J Public Health, 33, 365, 10.1111/j.1753-6405.2009.00409.x

Deutsch, 2009

Kim JJ, Brisson M, Edmunds WJ, et al. Modeling cervical cancer prevention in developed countries. Vaccine 26 (Suppl 10):K76–86.

Schiller, 2008, An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results, Vaccine, 26, K53, 10.1016/j.vaccine.2008.06.002